SGAM
INFI

Smith Group Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Smith Group Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-74,770
Closed -$632K – 519
2015
Q3 		$632K Sell
74,770
-806
-1% -$7.43K 0.02% 186
2015
Q2 		$828K Sell
75,576
-7,740
-9% -$99.3K 0.03% 179
2015
Q1 		$1.17M Buy
83,316
+4,526
+6% +$69.2K 0.04% 170
2014
Q4 		$1.33M Buy
+78,790
New +$1.15M 0.05% 164

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smith Group Asset Management's INFI Position: Q4 2015 in Review

Smith Group Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2015, closing a stake of 74,770 shares — an estimated $632K sold.

Smith Group Asset Management first reported a position in INFI in Q4 2014 and held it in 4 quarters. The position peaked at $1.33M in Q4 2014. 115 funds tracked by Wall St. Rank hold INFI as of Q4 2015.

  • Smith Group Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Smith Group Asset Management sold 74,770 Infinity Pharmaceuticals, Inc. shares in Q4 2015, an estimated $632K.
  • Smith Group Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
  • Smith Group Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $1.33M in Q4 2014.
  • 115 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2015.

Based on Smith Group Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.